Low dose aspirin and clinical outcomes in patients with SARS-CoV-2 pneumonia: a propensity score-matched cohort analysis from the National SIMI‑COVID‑19 Registry.
A DalbeniN SuscaM DaidoneI RossiA GiontellaA CimellaroG TalericoA PietrangeloG SestiVincenzo ZacconeR Villaninull nullPublished in: Internal and emergency medicine (2023)
66.2% were male, median age was 77 [70-83]. 34.8% of the population died during the hospitalization. Cardiovascular diseases were not significantly different between the groups. After comparison of LDA and no-LDA subgroups, we didn't record a significant difference in mortality rate (35.7% vs 33.7%) duration of hospital stay and ICU admission. In a logistic regression model, age (OR 1.05; 95% CI 1.01-1.09), FiO2 (OR 1.024; 95% CI 1.03-1.04) and days between symptoms onset and hospitalization (OR 0.93; 95% CI 0.87-0.99) were the only variables independently associated with death.
Keyphrases
- sars cov
- low dose
- cardiovascular disease
- cardiovascular events
- coronavirus disease
- respiratory syndrome coronavirus
- high dose
- emergency department
- intensive care unit
- healthcare
- quality improvement
- sleep quality
- coronary artery disease
- mechanical ventilation
- physical activity
- acute care
- clinical evaluation
- percutaneous coronary intervention
- extracorporeal membrane oxygenation